Xenotransplantation
Xenotransplantation has been studied in 28 papers since 2021: none in people yet, 1 in animals, 26 reviews; 22 in the past year. The research so far is in animals. The newest paper, Nov 17, 2026: “Precision immunopharmacology in xenotransplantation: integrating genome-engineered donors, organoid testbeds, and AI-guided translation”.
ExposurePreclinical
28 papers study it9 findingsUpdated
5 new papers in 30 daysSee all 28 papers on xenotransplantation
At a glance
A human trial preprint reports IL-1 signaling activation after paired pig liver and kidney xenotransplantation and increased SPP1/TREM2 macrophages in the liver. Direct human results come from one lab; reviews describe reduced graft rejection in non-human primates using multigene-modified pigs and improved feasibility in human compassionate-use cases.
9 findings in 7 papers from 2025 to 2026, 4 of them since August 2026
The findings reach people, from one lab or study. 1 lab in 1 country.
“Recipient-derived liver innate immune cells are C1Q-dominant at day 3 and 98.2% SPP1/TREM2 macrophages at day 11”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute of Allergy and Infectious Diseases and 2 more
- Animals1
What did studies of xenotransplantation find?
6Studies of xenotransplantation measured 6 outcomes, among them IL-1 signaling, SPP1/TREM2 macrophages and feasibility of heart, kidney, and liver xenotransplantation.
IL-1 signaling
upin humans1
1 study
IL-1 signaling
upin humans1
Xenotransplantation activates IL-1 signaling in humans (paired pig liver and kidney xenotransplantation).
Human trialpaired pig liver and kidney xenotransplantationn = 1
SPP1/TREM2 macrophages
upin humans1+98%
1 study
SPP1/TREM2 macrophages
upin humans1+98%
Xenotransplantation increases SPP1/TREM2 macrophages in humans (paired pig liver and kidney xenotransplantation) (98.2%).
Human trialpaired pig liver and kidney xenotransplantationliver11 daysn = 1
Feasibility of heart, kidney, and liver xenotransplantation
upin humans1
1 study
Feasibility of heart, kidney, and liver xenotransplantation
upin humans1
Xenotransplantation improves feasibility of heart, kidney, and liver xenotransplantation in humans (compassionate-use cases).
Reviewcompassionate-use cases
Graft rejection
downin non-human primates1
1 study
Graft rejection
downin non-human primates1
Xenotransplantation decreases graft rejection in non-human primates.
Reviewmultigene-modified pigs lacking glycan xenoantigens and expressing human complement/coagulation regulators
Graft survival
upin humans1
1 study
Graft survival
upin humans1
Xenotransplantation improves graft survival in humans (kidney xenograft in living recipient) (9 mo).
Reviewkidney xenograft in living recipient9 mon = 1
Hyperacute graft rejection
downin reviews1
1 study
Hyperacute graft rejection
downin reviews1
Xenotransplantation decreases hyperacute graft rejection.
Review
What is xenotransplantation linked with?
3Studies link xenotransplantation with 3 measures: immune-mediated graft injury, innate immune responses and organ compatibility.
Immune-mediated graft injury
upin humans1
1 study
Immune-mediated graft injury
upin humans1
Xenotransplantation is associated with immune-mediated graft injury in humans (clinical pig-to-human xenotransplantation).
Reviewclinical pig-to-human xenotransplantation
innate immune responses
upin reviews1
1 study
innate immune responses
upin reviews1
Xenotransplantation is associated with innate immune responses in xenotransplantation.
Reviewin xenotransplantation
Organ compatibility
no changein humans1
1 study
Organ compatibility
no changein humans1
Xenotransplantation is associated with organ compatibility in humans.
Review
Funding
12 grants since 2017National Institute of Allergy and Infectious Diseases$25.5MJapan Society for the Promotion of Science¥17.8MSão Paulo Research Foundation
Innovative Strategies to Inhibit Humoral Immunity in Renal Xenotransplantation
National Institute of Allergy and Infectious DiseasesUniversity of Pennsylvania$1.3M2026–2031
National Institute of Allergy and Infectious DiseasesEmory University$769K2026–2031
Preclinical Translation of Kidney, Heart, and Lung Xenotransplantation
National Institute of Allergy and Infectious DiseasesMassachusetts General Hospital$3.4M2025–2030
Xenotransplantation without Immunosuppressive Maintenance (XTWIM)
National Institute of Allergy and Infectious DiseasesColumbia University Health Sciences$3M2026–2031
Applying Genomics and Omics in Pig to Human Decedent Xenotransplantation
National Institute of Allergy and Infectious DiseasesNew York University School of Medicine$2.8M2025–2030
A Tolerance Approach to Xenotransplantation
National Institute of Allergy and Infectious DiseasesColumbia University Health Sciences$44.5K2000–2026
National Institute of Allergy and Infectious DiseasesNew York University School of Medicine$2.1M2026–2031
Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients
National Institute of Allergy and Infectious DiseasesDuke University$786K2023–2028
National Institute of Allergy and Infectious DiseasesDuke University$444K2025–2027
São Paulo Research Foundation2022–2029
How this record changed
Summary written from the findings.